Trial Condition(s):
BAY59-7939,Dose proportionality II for SPAF
Please see attached Study Results Summary below
No Inclusion Criteria Available
No Exclusion Criteria Available
Locations | Status | ||
---|---|---|---|
Locations CRS Clinical-Research-Services Mannheim GmbH Mannheim, Germany, 68167 | Status Completed | Contact Us: E-mail: [email protected] Phone: Not Available |